Animal pharm veterinary vaccines market in India

Animal pharm veterinary vaccines market in India

  • December 2015 •
  • 73 pages •
  • Report ID: 3605432 •
  • Format: PDF
This report fully covers the fast growing Indian animal vaccines market, which represents a high growth opportunity for prospective players There are currently very low levels of usage and availability of animal vaccines in India, so this area is expected to become the most important therapeutic segment over coming years

The author covers the significant opportunities arising by product and disease types, the various federal and provincial registration and approval authorities and the leading companies at the forefront of vaccines manufacturing and marketing in India

This is an indispensable guide for all those seeking to either invest in or know more about entering the fast-growing Indian animal health market and its vital vaccines segment

Key highlights

- One of the few bright spots in an otherwise challenging market - is the vaccines segment Being relatively high on innovation and requiring significantly higher investments in R&D and in manufacturing, the veterinary vaccines segment remains out of bounds for majority of small, local animal health companies in emerging markets such as India

Key features

- Opportunities arising by product and disease types

- The various federal and provincial registration and approval authorities

- The leading companies at the forefront of vaccines manufacturing and marketing in India


Key benefits

- Track how the fast growing Indian animal vaccines market will affect your business

- Identify new opportunities by product and disease types

- Make informed decisions by understanding who are the various federal and provincial registration and approval authorities

- Examine your competitors' activities by viewing the leading companies at the forefront of vaccines manufacturing and marketing in India
Loading...

We are very sorry, but an error occurred.
Please contact support@reportbuyer.com if the problem remains.